Literature DB >> 2210974

Can a relationship reflect the risk of calcium oxalate urolithiasis?

P Roca1, A Conte, T Riera, F Grases.   

Abstract

Different mathematical expressions have been proposed in the literature with the aim to reflect the risk of calcium oxalate urolithiasis. Such expressions, as well as a number of new relationships proposed by us, have been evaluated in 76 patients and 34 normal subjects. Stone-formers were divided into two groups: patients with normal calcium and oxalate excretion and patients with hypercalciuria and/or hyperoxaluria. The results obtained were comparatively evaluated. Several formulae gave some acceptable results, but none of them were excellent. This can be explained by the fact that these discrimination indexes more or less reflect supersaturation and/or inhibition deficit, but none of them reflect promoting factors such as heterogeneous nucleation and/or aggregation capacity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2210974     DOI: 10.1007/bf02550395

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  17 in total

1.  Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis.

Authors:  E Takasaki
Journal:  Invest Urol       Date:  1975-01

2.  The estimation of citrate in serum and urine using a citrate lyase technique.

Authors:  S G Welshman; H McCambridge
Journal:  Clin Chim Acta       Date:  1973-07-14       Impact factor: 3.786

3.  Ten years' experience with the use of thiazides in the prevention of kidney stones.

Authors:  E R Yendt; M Cohanim
Journal:  Trans Am Clin Climatol Assoc       Date:  1974

4.  Activity products in stone-forming and non-stone-forming urine.

Authors:  W G Robertson; M Peacock; B E Nordin
Journal:  Clin Sci       Date:  1968-06       Impact factor: 6.124

5.  The urinary calcium-magnesium ratio in calcigerous stone formers.

Authors:  J S King; F J O'Connor; M J Smith; L Crouse
Journal:  Invest Urol       Date:  1968-07

6.  Variations in the activity of urinary inhibitors in calcium oxalate urolithiasis.

Authors:  F Grases; C Genestar; P March; A Conte
Journal:  Br J Urol       Date:  1988-12

7.  Enzymic determination of urinary oxalate, with EDTA added to improve recovery.

Authors:  G D Cannon; R H Eaton; A C Glen; J Moncur
Journal:  Clin Chem       Date:  1983-10       Impact factor: 8.327

8.  A biochemical basis for grouping of patients with urolithiasis.

Authors:  H G Tiselius; L E Almgård; L Larsson; B Sörbo
Journal:  Eur Urol       Date:  1978       Impact factor: 20.096

9.  An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease.

Authors:  H G Tiselius
Journal:  Clin Chim Acta       Date:  1982-07-15       Impact factor: 3.786

10.  Biochemical evaluation of patients with urolithiasis.

Authors:  H G Tiselius; L Larsson
Journal:  Eur Urol       Date:  1981       Impact factor: 20.096

View more
  1 in total

1.  Renal stone formation and development.

Authors:  F Grases; O Söhnel; A Costa-Bauzá
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.